Atlas Trials

Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma

Clinical trial NCT02099292 · COMPLETED

Trial details

NCT number
NCT02099292
Sponsor
Georg Hess, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsed Non-Hodgkin-Lymphoma
Start date
2001-05-01
Primary completion
2005-05-01
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.